Wegovy maker Novo Nordisk extends losses following first-quarter results

Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on Thursday as analysts pored over the details of the firm’s first-quarter results and monitored a potential rival weight loss treatment. The company reported that sales for its blockbuster injectable weight loss treatment Wegovy, more than doubled to 9.38 billion Danish kroner ($1.4 … Read more

Jim Cramer shares his thoughts on TSLA, HTZ, PEP, SMCI and VRT

Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Tesla : Shares rose 5% after the electric vehicle maker announced plans to increase prices of its Model Y cars in April. “The stock is reacting positively. … It’s just been the worst stock in the [ S … Read more

Cramer’s rapid-fire look at UPS, Walmart, GM, Boeing, Novo Nordisk, Tesla

United Parcel Service — The stock continued lower Wednesday, one day after falling more than 8% on a disappointing 2024 revenue outlook and an announcement of 12,000 layoffs . Jim said, “I don’t know if [CEO] Carol Tome can keep the job.” The fact is, he added, e-commerce is very strong and “she’s not participating … Read more

Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday

Clorox – The consumer products giant saw a huge earnings beat. It’s also rebounding from last year’s cyberattack. “Things are back online, and there’s tremendous demand for their product,” Jim said Friday’s Morning Meeting rapid fire. Tesla – The EV leader issued a recall for 2.2 million cars over a warning light issue. Remember, our … Read more

Norway wealth fund says Novo, Eli Lilly may join trillion-dollar club

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.  George Frey | Reuters Norway’s giant wealth fund, the world’s largest, touted the possibility that Danish drugmaker Novo Nordisk and U.S. rival Eli Lilly … Read more